2022
Neonatal outcomes by delivery indication after administration of antenatal late preterm corticosteroids
Deshmukh U, Lundsberg L, Pettker C, Rouse D, Reddy U. Neonatal outcomes by delivery indication after administration of antenatal late preterm corticosteroids. AJOG Global Reports 2022, 2: 100097. PMID: 36536839, PMCID: PMC9758401, DOI: 10.1016/j.xagr.2022.100097.Peer-Reviewed Original ResearchPreterm prelabor ruptureLate preterm deliveryPreterm delivery groupLate preterm periodNeonatal respiratory complicationsPreterm labor groupPreterm deliverySpontaneous preterm laborPreterm laborPrelabor rupturePrimary outcomeDelivery indicationsDelivery groupAntenatal corticosteroidsNeonatal complicationsPlacebo groupRespiratory complicationsPreterm periodLower oddsAntenatal Late Preterm Steroids trialNewborn intensive care unit admissionIntensive care unit admissionMultivariable logistic regression modelLate preterm infantsNeonatal respiratory outcomes
2016
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman C, Thom E, Blackwell S, Tita A, Reddy U, Saade G, Rouse D, McKenna D, Clark E, Thorp J, Chien E, Peaceman A, Gibbs R, Swamy G, Norton M, Casey B, Caritis S, Tolosa J, Sorokin Y, VanDorsten J, Jain L. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. Obstetrical & Gynecological Survey 2016, 71: 453-455. DOI: 10.1097/01.ogx.0000489576.69844.54.Peer-Reviewed Original ResearchLate preterm periodPreterm periodMaternal-Fetal Medicine Units NetworkEunice Kennedy Shriver National InstituteLate preterm deliveryAdministration of betamethasoneAntenatal betamethasoneNeonatal morbidityPreterm deliveryMulticenter trialClinical centersChildhood complicationsChild healthNational InstituteBetamethasoneWomenRiskMorbidityComplicationsNewbornsInfantsAdministrationTrials